Apolipoprotein E receptors: Linking brain development and alzheimer's disease

Nature Reviews Neuroscience

Volumn 1, Issue 1, 2000, Pages 51-58

  Herz, Joachim ^a   Beffert, Uwe ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (29 40); AMYLOID BETA-PROTEIN (29-40); AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PEPTIDE FRAGMENT; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL; BRAIN; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; PHYSIOLOGY; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOLIPOPROTEINS E; BRAIN; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; PEPTIDE FRAGMENTS; RECEPTORS, LDL; RECEPTORS, LIPOPROTEIN; TAU PROTEINS;

EID: 0034305790     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/35036221     Document Type: Article

References (97)

1. Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D. & Mahley, R. W. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta 917, 148-161 (1987).
2. Pitas, R. E., Ji, Z. S., Weisgraber, K. H. & Mahley, R. W. Role of apolipoprotein E in modulating neurite outgrowth: potential effect of intracellular apolipoprotein E. Blochem. Soc. Trans. 26, 257-262 (1998).
3. Boyles, J. K. et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J. Clin. Invest. 83, 1015-1031 (1989).
4. Wolf, B. B., Lopes, M. B. S., VandenBerg, S. R. & Gonias, S. L. Characterization and immunohistochemical localization of a2-macroglobulin receptor (low density lipoprotein receptor-related protein) in human brain. Am. J. Pathol. 141, 37-42 (1992).
5. Schmechel, D. E. et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 9649-9653 (1993).
6. Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923 (1993).
7. Mahley, R. W. & Rall, S. C. in The Metabolic and Molecular Bases of Inherited Disease (eds Scriver, C. R., Beaudet, A. R., Sly, W. S. & Valle, D.) 1952-1980 (McGraw-Hill, New York, 1995).
8. Kounnas, M. Z. et al. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell 82, 331-340 (1995).
9. Blacker, D. et al. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nature Genet. 19, 357-360 (1998).
10. Kristensen, T. et al. Evidence that the newly cloned low- density-lipoprotein receptor related protein (LRP) is the a2- macroglobulin receptor FEBS Lett. 276, 151-155 (1990).
11. Strickland, D. K. et al. Sequence identity between the macroglobulin receptor and low density lipoprotein receptor- related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem. 265, 17401-17404 (1990).
12. Kang, D. E. et al. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 49, 56-61 (1997).
13. Herz, J., Clouthier, D. E. & Hammer, R. E. LDL receptor- related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation Cell 71, 411-421 (1992).Erratum, 73, 428 (1993).
14. Ishibashi, S. et al. Hypercholesterolemia in LDL receptor knockout mice And its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92, 883-893 (1993).
15. Frykman, P K., Brown, M. S., Yamamoto, T., Goldstein, J. L. & Herz, J. Normal plasma lipoproteins and fertility in gene- targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc. Natl Acad. Sci. USA 92, 8453-8457 (1995).
16. Willnow, T. E. et al. Defective forebrain development in mice lacking gp330/megalin. Proc. Natl Acad. Scl. USA 93, 8460-8464 (1996).
17. Trommsdorff, M. et al. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97, 689-701 (1999).
18. Nykjaer, A. et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96, 507-515 (1999).
19. Krieger, M. & Herz, J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Blochem. 63, 601-637 (1994).
20. Willnow, T. E. The low-density lipoprotein receptor gene family: multiple roles in lipid metabolism. J. Mol. Med. 77, 306-315 (1999).
21. Willnow, T. E., Nykjaer, A. & Herz, J. Lipoprotein receptors: new roles for ancient proteins. Nature Cell Blol. 1, E157-E162 (1999).
22. D'Arcangelo, G. et al. Reelin is a secreted glycoprotein recognized by the CR-50 monoclonal antibody. J. Neurosci. 17, 23-31 (1997).
23. Rice, D. S. & Curran, T. Mutant mice with scrambled brains: understanding the signaling pathways that control cell positioning in the CNS. Genes Dev. 13, 2758-2773 (1999).
24. Ware, M. L. et al. Aberrant splicing of a mouse disabled homolog, mdab1, in the scrambler mouse. Neuron 19, 239-249 (1997).
25. Sheldon, M. et al. Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice. Nature 389, 730-733 (1997).
26. Howell, B. W., Hawkes, R., Soriano, P. & Cooper, J. A. Neuronal position in the developing brain is regulated by mouse disabled-1. Nature 389, 733-737 (1997).
27. Falconer, D. S. Two new mutants 'trembler' and 'reeler' with neurological actions in the house mouse. J. Genet. 50, 192-201 (1951).
28. Hiesberger, T. et al. Direct binding of reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24, 481-489 (1999).
29. D'Arcangelo, G. et al. Reelin is a ligand for lipoprotein receptors. Neuron 24, 471-479 (1999).
30. Howell, B. W., Herrick, T. M. & Cooper, J. A. Reelin-induced tyrosine phosphorylation of disabled 1 during neuronal positioning. Genes Dev. 13, 643-648 (1999).
31. Trommsdorff, M., Borg, J. P., Margolis, B. & Herz, J. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 273, 33556-33560 (1998).
32. Chen, W. J., Goldstein, J. L. & Brown, M. S. NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. J. Biol. Chem. 265, 3116-3123 (1990).
33. Pawson, T. & Scott, J. D. Signaling through scaffold, anchoring, and adaptor proteins. Science 278, 2075-2080 (1997).
34. Pawson, T. & Nash, P. Protein-protein interactions define specificity in signal transduction. Genes Dev. 14, 1027-1047 (2000).
35. Guenette, S. Y., Chen, J., Jondro, P. D. & Tanzi, R. E. Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein. Proc. Natl Acad. Scl. USA 93, 10832-10837 (1996).
36. Bressler, S. L. et al. CDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein. Hum. Mol. Genet. 5, 1589-1598 (1996).
37. Gotthardt, M. et al. Interactions of the low density lipoprotein (LDL) receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J. Biol. Chem. 275, 25616-25624 (2000).
38. Howell, B. W., Lanier, L. M., Frank, R., Gertler, F. B. & Cooper, J. A. The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids. Mol. Cell Biol. 19, 5179-5188 (1999).
39. Senzaki, K., Ogawa, M. & Yagi, T. Proteins of the CNR family are multiple receptors for Reelin. Cell 99, 635-647 (1999).
40. Chae, T. et al. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18, 29-42 (1997).
41. Ohshima, T et al. Targeted disruption of the cyclin- dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl Acad. Scl. USA 93, 11173-11178 (1996).
42. Gilmore, E. C., Ohshima, T, Goffinet, A. M., Kulkarni, A. B. & Herrup, K. Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex. J. Neurosci. 18, 6370-6377 (1998).
43. Nikolic, M., Dudek, H., Kwon, Y. T., Ramos, Y. F. & Tsai, L. H. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10, 816-825 (1996).
44. Patrick, G. N. et al. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622 (1999).
45. Stockinger, W. et al. The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and 2. J. Biol. Chem. 275, 25625-25632 (2000).
46. D'Arcangelo, G. et al. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374, 719-723 (1995).
47. Ulery, P. G. et al. Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor- related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. J. Biol. Chem. 275, 7410-7415 (2000).
48. Selkoe, D. J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, A23-A31 (1999).
49. Vassar, R. et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741 (1999).
50. Yan, R. et al. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402, 533-537 (1999).
51. Sinha, S. et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402, 537-540 (1999).
52. Parvathy, S., Hussain, I., Karran, E. H., Turner, A. J. & Hooper, N. M. Cleavage of Alzheimer's amyloid precursor protein by alpha-secretase occurs at the surface of neuronal cells. Biochemistry 38, 9728-9734 (1999).
53. 2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-y. J. Clin. Invest. 91, 1219-1224 (1993).
54. Roses, A. D. & Saunders, A. Head injury, amyloid beta and Alzheimer's disease. Nature Med. 1, 603-604 (1995).
55. Guenette, S. Y. et al. hFE65L influences amyloid precursor protein maturation and secretion. J. Neurochem. 73, 985-993 (1999).
56. Sabo, S. L. et al. Regulation of beta-amyloid secretion by FE65, an amyloid protein precursor-binding protein. J. Biol. Chem. 274, 7952-7957 (1999).
57. Homayouni, R., Rice, D. S., Sheldon, M. & Curran, T. Dab1 binds to the cytoplasmic domain of the amyloid precursorlike protein 1. J. Neurosci. 19, 7507-7515. (1999).
58. Zambrano, N., Minopoli, G., de Candia, P & Russo, T The Fe65 adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1. J. Biol. Chem. 273, 20128-20133 (1998).
59. Lau, K. F., Miller, C. C., Anderton, B. H. & Shaw, P. C. Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter. Genomics 60, 121-128 (1999).
60. Holtzman, D. M. et al. Low density lipoprotein receptor- related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl Acad. Scl. USA 92, 9480-9484 (1995).
61. Nathan, B. P., Bellosta, S., Sanan, D. A., Mahley, R. W. & Pitas, R. E. Differential effects of apolipoproteins E3 and E4 on neuronal growth ln vitro. Science 264, 850-852 (1994).
62. Bellosta, S. et al. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. Chem. 270, 27063-27071 (1995).
63. LaDu, M. J. et al. Isoform-specific binding of apolipoprotein E to P-amyloid. J. Biol. Chem. 269, 23403-23406 (1994).
64. Qiu, W. Q. et al. Degradation of amyloid beta-protein by a serine protease-alpha2-macroglobulin complex. J. Biol. Chem. 271, 8443-8451 (1996).
65. Postuma, R. B. et al. Effects of the amyloid protein precursor of Alzheimer's disease and other ligands of the LDL receptor- related protein on neurite outgrowth from sympathetic neurons in culture. FEBS Lett. 428, 13-16 (1998).
66. Stockinger, W. et al. The low density lipoprotein receptor gene family. Differential expression of two alpha2- macroglobulin receptors in the brain. J. Biol. Chem. 273, 32213-32221 (1998).
67. Bales, K. R. et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nature Genet. 17, 263-264 (1997).
68. Lippa, C. F. et al. Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype. Neurology 48, 515-519 (1997).
69. Harada, A. et al. Altered microtubule organization in small- calibre axons of mice lacking tau protein. Nature 369, 488-491 (1994).
70. Hong, M. et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282, 1914-1917 (1998).
71. Ishihara, T. et al. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24, 751-762 (1999).
72. Genis, I., Gordon, I., Sehayek, E. & Michaelson, D. M. Phosphorylation of tau in apolipoprotein E-deficient mice. Neurosci. Lett. 199, 5-8 (1995).
73. Zhuo, M. et al. Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J. Neurosci. 20, 542-549 (2000).
74. Wolfe, M. S. et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398, 513-517 (1999).
75. Brown, M. S. & Goldstein, J. L. A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34-47 (1986).
76. Herz, J. et al. Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL- receptor suggest a physiological role as lipoprotein receptor. EMBO J. 7, 4119-4127 (1988).
77. Kim, D. H. et al. Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J. Biol. Chem. 271, 8373-8380 (1996).
78. Saito, A., Pietromonaco, S., Loo, A. K. & Farquhar, M. G. Complete cloning and sequencing of rat gp330/'megalin,' a distinctive member of the low density lipoprotein receptor gene family. Proc. Natl Acad. Scl. USA 91, 9725-9729 (1994).
79. Takahashi, S., Kawarabayasi, Y., Nakai, T., Sakai, J. & Yamamoto, T. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc. Natl Acad. Scl. USA 89, 9252-9256
80. Novak, S., Hiesberger, T., Schneider, W. J. & Nimpf, J. A new low density lipoprotein receptor homologue with 8 ligand binding repeats in brain of chicken and mouse J. Biol. Chem. 271, 11732-11736 (1996).Erratum, 271, 27188 (1996).
81. Schonbaum, C. P., Lee, S. & Mahowald, A. P. The Drosophlla yolkless gene encodes a vitellogenin receptor belonging to the low density lipoprotein receptor superfamily. Proc. Natl Acad. Scl. USA 92, 1485-1489 (1995).
82. Yochem, J. & Greenwald, I. A gene for a low density lipoprotein receptor-related protein in the nematode Caenorhabdltls elegans. J. Biol. Chem. 268, 13002-13009 (1993).
83. Rubin, G. M. et al. Comparative genomics of the eukaryotes. Science 287, 2204-2215 (2000).
84. Ermekova, K. S. et al. The WW domain of neural protein FE65 interacts with proline-rich motifs in Mena, the mammalian homolog of Drosophlla enabled. J. Biol. Chem. 272, 32869-32877 (1997).
85. Ahern-Djamali, S. M. et al. Mutations in Drosophlla enabled and rescue by human vasodilator-stimulated phosphoprotein (VASP) indicate important functional roles for Ena/VASP homology domain 1 (EVH1) and EVH2 domains. Mol. Blol. Cell 9, 2157-2171 (1998).
86. Gertler, F. B., Doctor, J. S. & Hoffmann, F. M. Genetic suppression of mutations in the Drosophlla abl proto- oncogene homolog. Science 248, 857-860 (1990).
87. Gertler, F. B., Hill, K. K., Clark, M. J. & Hoffmann, F. M. Dosage-sensitive modifiers of Drosophlla abl tyrosine kinase function: prospero, a regulator of axonal outgrowth, and disabled, a novel tyrosine kinase substrate Genes Dev. 7, 441-453 (1993). Erratum, 10, 2234 (1996).
88. Gertler, F. B., Niebuhr, K., Reinhard, M., Wehland, J. & Soriano, P. Mena, a relative of VASP and Drosophlla Enabled, is implicated in the control of microfilament dynamics. Cell 87, 227-239 (1996).
89. Lanier, L. M. et al. Mena is required for neurulation and commissure formation. Neuron 22, 313-325 (1999).
90. Yasuda, J., Whitmarsh, A. J., Cavanagh, J., Sharma, M. & Davis, R. J. The JIP group of mitogen-activated protein kinase scaffold proteins. Mol. Cell. Biol. 19, 7245-7254
91. Lammich, S. et al. Constitutive and regulated alpha- secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl Acad. Scl. USA 96, 3922-3927 (1999).
92. Buxbaum, J. D. et al. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273, 27765-27767 (1998).
93. Beffert, U., Arguin, C. & Poirier, J. The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease. Neurosci. Lett. 259, 29-32 (1999).
94. Fiore, F. et al. The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein. J. Biol. Chem. 270, 30853-30856 (1995).
95. Hu, Q. et al. The human FE65 gene: genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type. Hum. Genet. 103, 295-303 (1998).
96. Scott, W. K. et al. Fine mapping of the chromosome 12 late- onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity. Am. J. Hum. Genet. 66, 922-932 (2000).
97. Lewis, J. et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nature Genet. 25, 402-405 (2000).